1. Introduction {#sec1}
===============

*Shuang-huang-lian injection (SHLI)* is a typical Chinese herbal injection that is made from the extracts of *Flos Lonicerae Japonicae, Radix Scutellariae,* and *Fructus Forsythiae*. It has been widely used for the treatment of acute upper respiratory tract infections \[[@B1], [@B2]\]. Baicalin, chlorogenic acid, and forsythin are the marker compounds representing *Radix Scutellariae*, *Flos Lonicerae Japonicae,*   and *Fructus Forsythiae*, respectively, for the quality control of this medicine \[[@B3]\]. Though several published papers have reported the determination of major active components and metabolites in *Shuang-huang-lian (SHL)*preparations \[[@B4]--[@B6]\], there is no substantial evidence to confirm the holistic existing form of *SHLI* in vivo, especially in human body. Therefore, systematically, screening the constituents and metabolites of *SHLI*in human blood is of great significance for interpreting its material basis for pharmacological effects. Currently, the ingredients of *SHL* formula have been detected in rat blood \[[@B7]\]. However, the recent study suggests that species differences in key hepatic efflux transporters are sufficiently profound to warrant careful re-examination of conclusions and to design future studies with caution \[[@B8]\]. Some data have revealed that rat liver contains much more (\~10-fold) apical multidrug resistance-associated protein 2 (Mrp2) resulting in a much higher capacity for the biliary excretion of organic anions in rats than human or other preclinical species \[[@B9]\]. Therefore, to reveal the pharmacological mechanism of *SHLI*, comprehensive analysis of the constituents and metabolites in human body is more scientific and rational.

The process of metabolite detection and identification is typically a labor-intensive and time-consuming process. This process has been simplified by the use of radiolabeled compounds and/or spectroscopic techniques such as mass spectrometry and NMR spectroscopy \[[@B10]--[@B13]\]. Of these analysis techniques, liquid chromatography coupled with electrospray ionization mass spectrometer has been widely used to detect and identify trace levels of drugs and metabolites in various biological samples due to its high sensitivity and selectivity \[[@B14]--[@B16]\]. Ultra performance liquid chromatography (UPLC) applied for short run times combined with a quadrupole/time of flight-mass spectrometer (Q/TOF-MS) which offers high mass accuracy has become a major tool that provides a significant source of global constituent and metabolite profiling data \[[@B17]--[@B19]\]. Given the chemical complexity of *SHLI* in vivo, UPLC-Q-TOF/MS provides faster separations for complex blood samples and valuable structural insights into the characterization of *SHLI* metabolites.

A straightforward approach for identifying exogenous metabolites in vivo is to compare the LC-MS chromatograms of biological samples collected before and after xenobiotic treatment. However, without using effective analysis method, it is difficult to identify exogenous metabolites through visual examination of LC-MS chromatograms that contain information from thousands of chemical species \[[@B20]\]. A metabolomic strategy has been developed to handle the acquired data and to search for the discriminating features from biosample sets. A xenobiotic and its metabolites only appear in the samples after xenobiotic treatment, and so when using metabolomic strategy, the differences between the control group and the xenobiotic-treated group are mainly defined by the presence of the xenobiotic and its metabolites. With appropriate data processing, the separation of the control group and the xenobiotic-treated group can be achieved in the score plot of a multivariate model, and exogenous metabolites can be conveniently identified by analyzing ions contributing to the separation of the two groups. Employing this approach, the present study aims to develop a metabolomic strategy to comprehensively elucidate the prototype components and metabolites of *SHLI* in human serum conducted by UPLC-Q-TOF/MS.

2. Experiment {#sec2}
=============

2.1. Materials {#sec2.1}
--------------

*SHLI* was achieved from the Second Chinese Medicine Factory of Harbin Pharm. Group CO., Ltd. (No. 1204014). HPLC grade formic acid was obtained from Sigma Chemical Co., Ltd. (St. Louis, MO, USA). Methanol (HPLC grade) was acquired from Fisher Corporation (Michigan, USA). Water was purified with a Milli-Q system (Millipore, Bedford, USA).

2.2. Subjects and Clinical Trial Design {#sec2.2}
---------------------------------------

The study was approved by an independent ethics committee at Beijing University of Chinese Medicine, before recruitment commenced. Before the initiation of study procedures, all volunteers gave their written informed consent for participation in the study. Thirteen healthy volunteers, without taking any medication, participated in the study. They were aged between 25 and 40 years and with weight between 50 and 80 kg. After overnight fasting, early-morning blood samples (20 mL each) were collected from the medial cubital vein into evacuated tubes and marked as the control group (C group). Then participants were intravenous infusion of 60 mg/kg of *SHLI* (dissolved with 500 mL saline solution). The blood samples were collected at 0.5 h after *SHLI* administration and marked as *SHLI* dosed group (*SHLI* group). The blood supernatant was allowed to clot overnight at room temperature, and the clotted material was removed by centrifugation (3000 rpm, 15 min). The serum was collected and stored at −80°C.

2.3. Pretreatment Procedure for *SHLI* {#sec2.3}
--------------------------------------

The*Shuang-huang-lian* lyophilized powder for injection (0.1 g) was weighed and dissolved with 100 mL water. Then, it was filtered by a 0.22 *μ*m filter before UPLC-Q-TOF/MS analysis.

2.4. Pretreatment Procedure for Serum Samples {#sec2.4}
---------------------------------------------

All serum samples were thawed at room temperature followed by methanol protein precipitation. Serum (200 *μ*L) was added with 600 *μ*L methanol, vortexed for 30 s, and centrifuged at 14000 g for 10 min at 4°C. Then, supernatant (400 *μ*L) was transferred to a clean tube and evaporated to dryness under a gentle stream of nitrogen. The residue was redissolved with 100 *μ*L ultra high purity water and transferred to an autosampler vial.

2.5. UPLC-Q-TOF/MS Analysis {#sec2.5}
---------------------------

Separation and detection of the components and metabolites of *SHLI* were performed on a Waters Acquit UPLC chromatographic system (Waters Corp., Milford, USA) equipped with a Evoe G2 Q/TOF (Waters MS Technologies, Manchester, UK). An electrospray ionization source (ESI) interface was used in both positive and negative ion modes. Acquit UPLC HSS T3 column (2.1 mm × 100 mm, 1.8 *μ*m, Waters, UK) was applied for all analyses. The mobile phase was composed of A (0.1% formic acid in water) and B (methanol) with a linear gradient elution: 0--1 min, maintained at 0% B; 1--5 min, from 0% B to 40% B; 5--8 min, from 40% B to 100% B; 8--13 min, maintained at 0% B; 13.0--13.1 min, isocratic of 0% B; 13.1--15 min, maintained at 0% B. The flow rate was 0.30 L/min. The analytic column and autosampler were maintained at temperatures of 45°C and 4°C, respectively. Then, 1 *μ*L of sample solution was injected for each run. Data were collected from *m/z* 50 to *m/z* 1200. For positive ion mode, the capillary and cone voltage were set at 3 kV and 35 V. For negative ion mode, the capillary and cone voltage were set at 2.5 kV and 35 V. The conservation gas was set at 700 L/h at a temperature of 350°C. The source temperature was set at 100°C. The cone gas was set at 50 L/h. Leucine-enkephalin was used as the lock mass solution to ensure the accuracy and reproducibility.

2.6. Data Processing and Statistical Analysis {#sec2.6}
---------------------------------------------

The ES+ and ES− raw data was analyzed by MarkerLynx XS software (Waters Corp., Milford, USA). For extracting data from the raw file and detecting potential markers, the retention time range was set at 0--13 min, the mass range at 50--1000 amu, and the mass tolerance as 0.01. For detecting chromatographic peaks in the Apex Track Peak, peak width at 5% height was set at 1.00, and the peak-to-peak baseline noise was 0.00. For collecting parameters, the marker intensity threshold was set at 1000 cps, the mass window was 0.02 amu, and retention time window was 0.20 min. The noise elimination level was 6. This process provided alignment of drift (retention time and accurate mass) in data and ensured that a chromatographic peak was identified with the same parameters in each sample. Subsequently, a list of intensities or peak areas of the peaks was then generated for the first chromatogram, using the ER-*m/z* pairs as identifiers. The procedure was applied for each UPLC/MS analysis. The ion intensities or peak area for each peak detected was also normalized within each sample to the sum of the peak intensities in that sample. The three-dimensional data were introduced into the EZinfo 2.0 software (Waters Corporation, Milford, MA, USA) for orthogonal partial least-squares-discriminate analysis (OPLS-DA).

3. Results and Discussion {#sec3}
=========================

3.1. Identification and Analysis of Chemical Components in *SHLI* {#sec3.1}
-----------------------------------------------------------------

Global profiling of both positive and negative ion modes was analyzed by UPLC-Q-TOF/MS. The typical base peak intensity (BPI) chromatograms (positive ion mode and negative ion mode) of *SHLI* were shown in [Figure 1](#fig1){ref-type="fig"}. In total, 38 constituents were detected and tentatively characterized in *SHLI* ([Table 1](#tab1){ref-type="table"}). MS^E^ technique, a new technique used in deducing the splitting disciplinary of MS, was applied to data collection. MS^E^ technique could provide parallel alternating scans for acquisition at low collision energy to obtain precursor ion information or at a ramping of high collision energy to obtain a full-scan accurate mass of fragments, precursor ions, and neutral loss information \[[@B21], [@B22]\]. Here, the high precision MS/MS fragments information obtained from the MS^E^ technique were also listed in [Table 1](#tab1){ref-type="table"} to explain the structure information of the chemical constituents. All the constituents and the fragmentation information were consistent with previous reports \[[@B23], [@B24]\].

3.2. Analysis of Human Serum by Metabolomic Strategy {#sec3.2}
----------------------------------------------------

[Figure 2](#fig2){ref-type="fig"} represented the typical BPI chromatograms (positive ion mode and negative ion mode) of human serum samples before and after *SHLI* administration. The prototype components and metabolites of *SHLI*in human serum were almost submerged by the endogenous metabolites due to the high level of endogenous signals. Interferences from biological matrices remain a major challenge to detection of metabolites in vivo. Without the presence of a radiolabeled isotope or a data-mining tool, it would be almost impossible to identify low level exogenous metabolites. In our work, a metabolomic strategy was employed to phenotype the differences between C group and *SHLI* group. The LC/MS data were processed using MarkerLynx XS to detect peaks and generate a three-dimensional data with *t* ~*R*~-*m/z* pairs and the corresponding intensities. Statistical analysis by OPLS-DA was subsequently performed on the entire dataset. [Figure 3](#fig3){ref-type="fig"} showed the OPLS-DA score plots of human serum samples before and after *SHLI* injection. Clear separation was observed between the two groups, which indicated that the drug-induced constituents were contributed to the clustering.

3.3. Identification and Analysis of Prototype Components and Metabolites {#sec3.3}
------------------------------------------------------------------------

In order to discover the multiple prototype components and metabolites of *SHLI* in human serum, S-plot, a tool for visualization and interpretation of multivariate classification models, was used. In the S-plot, each point represented an ion detected by UPLC-Q-TOF/MS. Variables that were the farthest from the origin in the S-plot were representative of the most significant changes between the two groups. Based on this, even subtle differences in the two groups could be easily extracted. [Figure 4](#fig4){ref-type="fig"} showed the ions in S-plot that were most responsible for distinguishing the C and *SHLI* groups and had a higher level in *SHLI* group.

The S-plot responsible for the variances in the data was a combination of metabolites derived from the *SHLI* administration and endogenous molecules which were ubiquitous to serum and were interfered by *SHLI*. From a drug metabolite identification perspective, it was important that the disturbance endogenous molecules could be eliminated, and the prototype components and metabolites could be easily screened between *SHLI*-treated group and the control group. This comparison was achieved by using the trend plot. From the trend plots, the variables that only existed in the dosed serums were marked as the prototype components or the metabolites of *SHLI*. [Figure 5](#fig5){ref-type="fig"} showed the visualized trend plot of 7.41-285.0762 in positive mode between C group and *SHLI*group. The ion only appeared in the *SHLI* group. Therefore, 7.41-285.0762 might be a prototype component or a metabolite of *SHLI*.

Based on the metabolomic strategy, 35 exogenous components in human serum were found, among them, 23 prototype components of *SHLI* and 12 metabolites were identified and their information was shown in [Table 2](#tab2){ref-type="table"}.

3.4. Characterization Analysis of Human Serum Prototype Components and Metabolites of *SHLI* {#sec3.4}
--------------------------------------------------------------------------------------------

In our study, the prototype components and metabolites of *SHLI* were identified by comparing the accurate mass and MS^E^ fragment information obtained from the MS^E^ technique. [Figure 6](#fig6){ref-type="fig"} showed typical MS/MS spectra of the prototype component 6.23-461.1079 and the flavonoid metabolite 6.46-363.0174. In positive ion mode, the ion at *m/z* 483.0906 was \[M + Na\]^+^ion. The dominant fragment ion of *m/z*285.0763 was produced by loss of *m/z* 176 (glucuronide-H~2~O) fragment from \[M + H\]^+^ in positive ion mode. The characteristic and abundant fragment ion \[M + H-CH~3~\]^+•^ was generated by loss of CH~3~ ^•^ for the flavones with a methoxyl group on the side chains of an aromatic ring. Its molecular formula was speculated to be C~22~H~21~O~11~ based on the analysis of its elemental composition. Then the ion at *m/z* 483.0906 was inferred as wogonoside. The ion at *m/z* 363.0168 was \[M − H\] ^−^ ion. The major fragment ion of *m/z* 283.0606 was generated by loss of *m/z* 80 (sulfate-H~2~O) fragment from \[M − H\]^−^ in negative ion mode. The molecular formula was speculated to be C~16~H~12~O~8~S, and the fragmentation information and the molecular formula were consistent with wogonin 7-sulfate. Other metabolites were determined by the same method described above and some of them were also supported by the databases such as HMDB (<http://www.hmdb.ca/>) and METLIN (<http://masspec.scripps.edu/>). As a result, 23 prototype components and 12 metabolites of *SHLI* were identified.

3.5. Correlative Analysis of the Prototype Components and Metabolites of *SHLI* {#sec3.5}
-------------------------------------------------------------------------------

The prototype herb components could be further metabolized by various drug metabolizing enzymes. Drug metabolism is classified into phase I and phase II reactions. Phase I reactions are mediated primarily by the cytochrome P450 family of microsomal enzymes \[[@B25]\]. Compounds are factionalized by oxidation, hydrolysis, or reduction, leading to the introduction of, for example, hydroxyl, amino, carboxyl, or thiol groups into the molecule. Most compounds undergo phase I oxidation prior to phase II conjugation, but molecules with sites amenable to conjugation may undergo phase II reactions directly. The most relevant phase II drug conjugation reactions are methylation, sulfation, glucuronidation, and glutathione conjugation. There were three types of components found in human serum after *SHLI* administration: (i) compounds found in their native form; (ii) phase I metabolites formed by chemical modifications, such as hydroxylation (M + OH) and hydration (M + H~2~O), and (iii) phase II metabolites formed by conjugation, such as methylation (M + CH~3~), glucuronidation (M + C~6~H~8~O~6~), sulfation (M + HSO~3~), and other conjugation reactions. In human serum, a large number of phase II metabolites were found. Among them, 8 flavonoids metabolites, 2 phenylephrine glycosides metabolites, 1 iridoid metabolite, and 1 quinic acid metabolite were found.

Some researchers have reported the metabolites of *SHL* formula in rat plasma \[[@B8]\]. We compared the metabolites differences in human and rats after *SHLI* administration and found great differences on the types and quantities of the metabolites after*SHLI* or*SHL* formula administrated between human and rats. The metabolites of *SHLI* found in rats and human were listed in Supplementary Material (see Table S1 in Supplementary Material available online at <http://dx.doi.org/10.1155/2014/241505>). Large number of phase I metabolites were detected in rats such as dihydrosecologanic acid and 3,4-dihydroxyphenylethanol, while little was found in the human serum. Besides, sulfated metabolites which were common in human serum were less detected in the rat plasma. Such a discrepancy might be attributed to different species (human or rats), prescription (*SHLI* or*SHL* formula), or blood collection time (1 h or shorter time). Further studies of the biological properties of these metabolites would be helpful to understand the pharmacological mechanism of*SHLI*.

4. Conclusion {#sec4}
=============

In this paper, we developed an unbiased approach for screening the prototype components and metabolites of *SHLI*in human serum based on metabolomic technique. Employing UPLC-Q-TOF-MS combined with multivariate statistical analysis, 23 prototype components and 12 metabolites of *SHLI* were rapidly and sensitively identified, which suggested that the metabolomic approach was an effective tool to discover, screen, and analyze the multiple prototype components and metabolites from complicated traditional Chinese preparations in vivo. *SHLI* in human body mainly caused phase II metabolite reactions such as sulfation, methylation, glucuronidation, and other complex conjugation reactions. This identification and structural elucidation of the chemical compounds provided essential data for further pharmacological and pharmacokinetics study of *SHLI*. The human serum metabolomic approach avoids the laborious process of predicting possible metabolites and provides information on unexpected reactive metabolites and a type of validated rapid and higher throughput methodology for the identification of constituents of traditional Chinese medicine.

Supplementary Material {#supplementary-material-sec}
======================
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![UPLC-Q-TOF/MS BPI chromatograms of *SHLI* in positive ion mode and negative ion mode.](JAMC2014-241505.001){#fig1}

![UPLC-Q-TOF/MS BPI chromatograms of human serum samples (a) before *SHLI* administration in positive ion mode, (b) after *SHLI* administration in positive ion mode, (c) before *SHLI* administration in negative ion mode, and (d) after *SHLI* administration in negative ion mode.](JAMC2014-241505.002){#fig2}

![Score plots of OPLS-DA in human serum samples between C group (■) and *SHLI*group (▲) in (a) positive ion mode and (b) negative ion mode.](JAMC2014-241505.003){#fig3}

![S-plots of human serum samples between C and *SHLI* groups in (a) positive ion mode and (b) negative ion mode. The ions marked with box were at the higher level in *SHLI* group.](JAMC2014-241505.004){#fig4}

![The trend plot of 7.41-285.0762 in positive mode between C group (■) and*SHLI* group (▲).](JAMC2014-241505.005){#fig5}

![MS/MS spectra and structures of (a) prototype compound wogonoside in positive ion mode and (b) flavonoids metabolite wogonin 7-sulfate in negative ion mode identified in human serum after *SHLI* administration. In the tag, glu was the abbreviation of glucuronide-H~2~O and sul was the abbreviation of sulfate-H~2~O.](JAMC2014-241505.006){#fig6}

###### 

UPLC-Q-TOF/MS identification of the constituents in *SHLI*.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  NO.   *t* ~*R*~ (min)   Positive ion MS   Negative ion MS   Formula           Identification                                     Positive ion\   Negative ion\   Class
                                                                                                                                   MS/MS           MS/MS           
  ----- ----------------- ----------------- ----------------- ----------------- -------------------------------------------------- --------------- --------------- --------------------------
  1     0.88              193.0722          191.0557          C~7~H~12~O~6~     Quinic acid                                        112.0521\       127.0400\       Quinic acid
                                                                                                                                                   85.0288         

  2     3.77              355.1033          353.0873          C~16~H~18~O~9~    Chlorogenic acid                                   163.0395\       191.0549\       Quinic acid
                                                                                                                                   145.0279\       179.0341\       
                                                                                                                                   135.0454        135.0449        

  3     3.87              ---               375.1287          C~16~H~24~O~10~   Isomer of loganic acid                             ---             213.0765\       Iridoid
                                                                                                                                                   169.0867\       
                                                                                                                                                   151.0759        

  4     3.90              623.2080          ---               C~29~H~34~O~15~   Isomer of suspensaside A                           191.0568\       461.1674\       Phenylethanoid glycoside
                                                                                                                                   149.0232        443.1554\       
                                                                                                                                                   205.0319        

  5     3.97              ---               461.1659          C~20~H~30~O~12~   Forsythoside E                                     ---             315.1076\       Phenylethanoid glycoside
                                                                                                                                                   205.0718\       
                                                                                                                                                   135.0448        

  6     4.20              ---               375.1287          C~16~H~24~O~10~   Loganic acid\                                      ---             213.0778\       Iridoid
                                                                                                                                                   169.0853\       
                                                                                                                                                   151.0773        

  7     4.24              355.1023          353.0866          C~16~H~18~O~9~    3-O-Caffeoylquinic acid                            163.0393\       191.0569\       Quinic acid
                                                                                                                                   145.0286        179.0365        

  8     4.29              ---               353.0873          C~16~H~18~O~9~    4-O-Caffeoylquinic acid                            ---             173.0450\       Quinic acid
                                                                                                                                                   135.0453        

  9     4.35              ---               639.1925          C~29~H~36~O~16~   Suspensaside                                       ---             621.1841\       Phenylethanoid glycoside
                                                                                                                                                   469.1273        

  10    4.43              375.1288          373.1129          C~16~H~22~O~10~   Secologanic acid                                   213.0749\       193.0494\       Iridoid
                                                                                                                                   195.0638        149.0605        

  11    4.45              391.1255          389.1074          C~16~H~22~O~11~   Monotropein                                        211.0586\       209.0455\       Iridoid
                                                                                                                                   177.0546\       165.0554\       
                                                                                                                                   151.0395        149.0605        

  12    4.58              ---               639.1918          C~29~H~36~O~16~   Isomer of suspensaside                             ---             445.1318\       Phenylethanoid glycoside
                                                                                                                                                   205.0318\       
                                                                                                                                                   179.0346        

  13    4.72              ---               403.1239          C~17~H~24~O~11~   Isomer of secoxyloganin                            ---             241.1177        Iridoid

  14    4.73              359.1348          ---               C~16~H~22~O~9~    Sweroside                                          197.0812\       ---             Iridoid
                                                                                                                                   151.0400                        

  15    4.80              625.2124          623.1982          C~29~H~36~O~15~   Acteoside                                          471.1504\       461.1671\       Phenylethanoid glycoside
                                                                                                                                   325.0927\       443.1567\       
                                                                                                                                   163.0398        203.0428        

  16    4.89              ---               755.2399          C~34~H~44~O~19~   Forsythoside B                                     ---             593.2103\       Phenylethanoid glycoside
                                                                                                                                                   447.1500\       
                                                                                                                                                   315.1137        

  17    4.93              623.1986          621.1816          C~29~H~34~O~15~   Suspensaside A                                     191.0571\       487.1371\       Phenylethanoid glycoside
                                                                                                                                   149.0234        469.1180        

  18    5.03              625.2133          623.1970          C~29~H~36~O~15~   Forsythoside A                                     471.1512\       461.1671\       Phenylethanoid glycoside
                                                                                                                                   325.0919\       443.1567\       
                                                                                                                                   163.0398        205.0321        

  19    5.06              405.1387          403.1236          C~17~H~24~O~11~   Secoxyloganin                                      243.0880\       371.0979\       Iridoid
                                                                                                                                   211.0612        223.0611        

  20    5.09              ---               515.1174          C~25~H~24~O~12~   3,4-Dicaffeoylquinic\                              ---             353.0906\       Quinic acid
                                                                                acid                                                               191.0561\       
                                                                                                                                                   135.0446        

  21    5.13              ---               515.1174          C~25~H~24~O~12~   3,5-Dicaffeoylquinic\                              ---             353.0906\       Quinic acid
                                                                                acid                                                               173.0355\       
                                                                                                                                                   135.0446        

  22    5.21              ---               519.1863          C~26~H~32~O~11~   Pinoresinol 4-O-glucoside                          ---             357.1336\       Lignan
                                                                                                                                                   151.0398\       
                                                                                                                                                   136.0164        

  23    5.30              463.0876          461.0730          C~21~H~18~O~12~   Luteolin 7-galacturonide                           287.0552\       285.0399\       Flavonoid
                                                                                                                                   269.0462\       211.0400\       
                                                                                                                                   241.0493        113.0238        

  24    5.32              ---               447.0927          C~21~H~20~O~11~   5,6-Dihydroxy flavanone-7-O-glucuronide            ---             285.0399\       Flavonoid
                                                                                                                                                   267.0309\       
                                                                                                                                                   239.0356        

  25    5.35              ---               621.1788          C~29~H~34~O~15~   Suspensaside A                                     ---             487.1510\       Phenylethanoid glycoside
                                                                                                                                                   179.0351        

  26    5.37              611.1599          609.1453          C~27~H~30~O~16~   Rutin                                              465.1016\       300.0253\       Flavonoid
                                                                                                                                   303.1489\       271.0236\       
                                                                                                                                                   255.0290        

  27    5.38              517.1344          515.1186          C~25~H~24~O~12~   4,5-Dicaffeoylquinic\                              499.1206\       353.0866\       Quinic acid
                                                                                acid                                               355.1702\       191.0553\       
                                                                                                                                   337.0856        173.0451        

  28    5.54              ---               757.2550          C~34~H~46~O~19~   Centauroside                                       ---             525.1569\       Iridoid
                                                                                                                                                   493.1695\       
                                                                                                                                                   179.0511        

  29    5.78              ---               533.2020          C~27~H~34~O~11~   Phillyrin                                          ---             371.1484\       Lignan
                                                                                                                                                   356.1257\       
                                                                                                                                                   121.0295        

  30    5.88              447.0925          445.0771          C~21~H~18~O~11~   Baicalin                                           271.0603        269.0455\       Flavonoid
                                                                                                                                                   241.0503        

  31    6.01              477.1027          475.0876          C~22~H~19~O~12~   5,2′-Dihydroxy-6′-methoxyflavone-7-O-glucuronide   301.0713\       443.0556\       Flavonoid
                                                                                                                                                   299.0546        

  32    6.17              431.0978          429.0815          C~21~H~18~O~10~   Chrysin 7-glucuronide                              255.0658        253.0505        Flavonoid

  33    6.23              461.1079          459.0927          C~22~H~20~O~11~   Wogonoside                                         285.0767\       283.0611\       Flavonoid
                                                                                                                                   270.0534        268.0375\       
                                                                                                                                                   239.0345        

  34    6.38              ---               445.0779          C~21~H~18~O~11~   Norwogonin-7-O-glucuronide                         ---             269.0422        Flavonoid

  35    6.81              271.0608          269.0446          C~15~H~10~O~5~    Baicalein                                          271.0623\       251.0362\       Flavonoid
                                                                                                                                   253.0498\       223.0379\       
                                                                                                                                   123.0083        195.0447        

  36    7.26              285.0761          283.0602          C~16~H~12~O~5~    Wogonin                                            270.0489\       268.0377\       Flavonoid
                                                                                                                                                   162.9845        

  37    7.35              255.0654          ---               C~15~H~10~O~4~    Chrysin                                            153.0173        ---             Flavonoid

  38    7.40              285.0762          283.0601          C~16~H~12~O~5~    Isomer of wogonin                                  270.0489        268.0409        Flavonoid
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

The prototype components and metabolites in human serum after *SHLI* dosed in both positive and negative mode.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  NO.   *t* ~*R*~ (min)   Positive ion MS   Negative ion MS   Formula            Identification                                                                                                                             Positive ion\   Negative ion\   Relegation
                                                                                                                                                                                                                            MS/MS           MS/MS           
  ----- ----------------- ----------------- ----------------- ------------------ ------------------------------------------------------------------------------------------------------------------------------------------ --------------- --------------- -----------------------------------------
  1     0.88              193.0722          191.0557          C~7~H~12~O~6~      Quinic acid                                                                                                                                112.0521\       127.0400\       Prototype component
                                                                                                                                                                                                                                            85.0288         

  2     3.77              355.1033          353.0873          C~16~H~18~O~9~     Chlorogenic acid                                                                                                                           163.0395\       191.0549\       Prototype component
                                                                                                                                                                                                                            145.0279\       179.0341\       
                                                                                                                                                                                                                            135.0454        135.0449        

  3     3.87              ---               375.1287          C~16~H~24~O~10~    Isomer of loganic acid                                                                                                                     ---             213.0765\       Prototype component
                                                                                                                                                                                                                                            169.0867\       
                                                                                                                                                                                                                                            151.0759        

  4     4.20              ---               375.1287                             Loganic acid                                                                                                                               ---             213.0778\       Prototype component
                                                                                                                                                                                                                                            169.0853\       
                                                                                                                                                                                                                                            151.0773        

  5     4.24              ---               353.0873          C~16~H~18~O~9~     3-O-Caffeoylquinic acid                                                                                                                    ---             191.0569\       Prototype component
                                                                                                                                                                                                                                            179.0365        

  6     4.29              ---               353.0873          C~16~H~18~O~9~     4-O-Caffeoylquinic acid                                                                                                                    ---             173.0450\       Prototype component
                                                                                                                                                                                                                                            135.0453        

  7     4.37              478.1365          ---               C~22~H~23~NO~11~   Isorhamnetin 7-glucosamine                                                                                                                 316.0847\       ---             Metabolite of flavonoids
                                                                                                                                                                                                                            298.0745\                       
                                                                                                                                                                                                                            280.0654                        

  8     4.42              ---               475.1816          C~21~H~32~O~12~    Kanokoside A                                                                                                                               ---             313.0276\       Metabolite of iridoids
                                                                                                                                                                                                                                            193.0493\       
                                                                                                                                                                                                                                            123.0452        

  9     4.43              375.1288          373.1129          C~16~H~22~O~10~    Secologanic acid                                                                                                                           213.0749\       193.0494\       Prototype component
                                                                                                                                                                                                                            195.0638        149.0605        

  10    4.45              ---               389.1074          C~16~H~22~O~11~    Monotropein                                                                                                                                ---             209.0455        Prototype component

  11    4.57              ---               369.0815          C~16~H~18~O~10~    Ferulic acid 4-O-glucuronide                                                                                                               ---             193.0490\       Metabolite of quinic acids
                                                                                                                                                                                                                                            178.0263        

  12    4.72              ---               403.1239          C~17~H~24~O~11~    Isomer of secoxyloganin                                                                                                                    ---             241.1177        Prototype component

  13    4.73              359.1348          ---               C~16~H~22~O~9~     Sweroside                                                                                                                                  197.0812\       ---             Prototype component
                                                                                                                                                                                                                            151.0400                        

  14    5.03              ---               731.1866          C~31~H~40~O~18~S   Methylated and sulfated forsythiaside                                                                                                      ---             651.2212\       Metabolite of phenylethanoid glycosides
                                                                                                                                                                                                                                            457.1421        

  15    5.06              405.1387          403.1236          C~17~H~24~O~11~    Secoxyloganin                                                                                                                              243.0880\       371.0979\       Prototype component
                                                                                                                                                                                                                            211.0612        223.0611        

  16    5.09              ---               515.1174          C~25~H~24~O~12~    3,4-Dicaffeoylquinic\                                                                                                                      ---             353.0906\       Prototype component
                                                                                 acid                                                                                                                                                       191.0561\       
                                                                                                                                                                                                                                            135.0446        

  17    5.16              623.1266          621.1092          C~27~H~26~O~17~    Genistein 4′,7-O-diglucuronide                                                                                                             447.0916\       445.0765\       Metabolite of flavonoids
                                                                                                                                                                                                                            271.0607        357.1336\       
                                                                                                                                                                                                                                            269.0444        

  18    5.20              ---               827.2600          C~37~H~48~O~21~    2-(3,4-Dihydroxyphenyl)ethyl6-deoxy-mannopyranosyl-glucopyranosyl-2-O-acetyl-4-O-\[3-(3,4-dihydroxyphenyl)-2-propenoyl\]-glucopyranoside   ---             520.1801\       Metabolite of phenylethanoid glycosides
                                                                                                                                                                                                                                            429.1375\       
                                                                                                                                                                                                                                            437.0904        

  19    5.21              ---               519.1863          C~26~H~32~O~11~    Pinoresinol 4-O-glucoside                                                                                                                  ---             357.1336\       Prototype component
                                                                                                                                                                                                                                            151.0398\       
                                                                                                                                                                                                                                            136.0164        

  20    5.47              623.1250          621.1088          C~27~H~26~O~17~    Baicalein 6,7-diglucuronide                                                                                                                447.0922\       445.0774\       Metabolite of flavonoids
                                                                                                                                                                                                                            271.0605        269.0452        

  21    5.54              609.1461          607.1299          C~27~H~28~O~16~    Luteolin 7-glucuronide-4′-rhamnoside                                                                                                       447.0919\       431.0965        Metabolite of flavonoids
                                                                                                                                                                                                                            271.0610                        

  22    5.54              ---               757.2550          C~34~H~46~O~19~    Centauroside                                                                                                                               ---             525.1569\       Prototype components
                                                                                                                                                                                                                                            493.1695\       
                                                                                                                                                                                                                                            179.0511        

  23    5.69              ---               287.0234          C~11~H~12~O~7~S    5′-(3′,4′-Dihydroxyphenyl)-gamma-\                                                                                                         ---             207.0651\       Metabolite of flavonoids
                                                                                 valerolactone sulfate                                                                                                                                      179.0334\       
                                                                                                                                                                                                                                            135.0437        

  24    5.78              ---               533.2020          C~27~H~34~O~11~    Phillyrin                                                                                                                                  ---             371.1484\       Prototype component
                                                                                                                                                                                                                                            356.1257\       
                                                                                                                                                                                                                                            121.0295        

  25    5.88              447.0925          445.0771          C~21~H~18~O~11~    Baicalin\                                                                                                                                  271.0603        269.0455\       Prototype component
                                                                                                                                                                                                                                            241.0503        

  26    6.17              431.0969          429.0815          C~21~H~18~O~10~    Chrysin 7-glucuronide                                                                                                                      255.0645        253.0505        Prototype component

  27    6.23              461.1079          459.0927          C~22~H~20~O~11~    Wogonoside                                                                                                                                 285.0760        283.0611\       Prototype component
                                                                                                                                                                                                                                            268.0375\       
                                                                                                                                                                                                                                            239.0345        

  28    6.38              ---               445.0779          C~21~H~18~O~11~    Norwogonin-7-O-glucuronide                                                                                                                 ---             269.0449\       Prototype component
                                                                                                                                                                                                                                            131.0625        

  29    6.41              ---               349.0014          C~15~H~10~O~8~S    Baicalein 7-sulfate                                                                                                                        ---             269.0449\       Metabolite of flavonoids

  30    6.43              ---               363.0174          C~16~H~12~O~8~S    Wogonin 7-sulfate                                                                                                                          ---             283.0606        Metabolite of flavonoids

  31    6.46              ---               283.0607          C~16~H~12~O~5~     7,5-Dihydroxy-6-methoxyflavone                                                                                                             ---             268.0371\       Metabolite of flavonoids

  32    6.81              271.0608          269.0446          C~15~H~10~O~5~     Baicalein                                                                                                                                  271.0623\       251.0362\       Prototype component
                                                                                                                                                                                                                            253.0498\       223.0379\       
                                                                                                                                                                                                                            123.0083        195.0447        

  33    7.26              285.0761          283.0602          C~16~H~12~O~5~     Wogonin                                                                                                                                    270.0489\       268.0377\       Prototype component
                                                                                                                                                                                                                                            162.9845        

  34    7.35              255.0654          ---               C~15~H~10~O~4~     Chrysin                                                                                                                                    153.0173        ---             Prototype component

  35    7.41              285.0761          283.0601          C~16~H~12~O~5~     Wogonin                                                                                                                                    270.0502        268.0409        Prototype component
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
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